Anticarcinogenic Agents
-
Subject Areas on Research
- Analgesic medication use and risk of epithelial ovarian cancer in African American women.
- Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
- Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
- Association of aspirin use and hormone receptor status with breast cancer risk.
- Association of aspirin use and hormone receptor status with breast cancer risk.
- Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
- Breast cancer anxiety's associations with responses to a chemoprevention decision aid.
- Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
- Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid.
- Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Distinguishing effects on tumor multiplicity and growth rate in chemoprevention experiments.
- Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity.
- Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging.
- Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats.
- Gene duplication in the diversification of secondary metabolism: tandem 2-oxoglutarate-dependent dioxygenases control glucosinolate biosynthesis in Arabidopsis.
- Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones.
- Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen.
- Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).
- Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer.
- Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
- Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
- Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.
- Resveratrol arrests the cell division cycle at S/G2 phase transition.
- Safety and efficacy of weekly oral oltipraz in chronic smokers.
- Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice.
- Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice.
- Tamoxifen reduces plasma homocysteine levels in healthy women.
- The epidemiology of tea consumption and colorectal cancer incidence.
- The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
- The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
- Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
- Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
- Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.
- Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.